Data / Form D filings / BioVaxys Technology Corp.
BioVaxys Technology Corp.: Form D filings
BioVaxys Technology Corp., a biotechnology company in Etobicoke, Ontario, Canada, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on July 12, 2024, reports $52,324 sold of a $173,071 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 146 THIRTIETH STREET, SUITE 100, Etobicoke, Ontario, Canada, M8W 3
- Phone
- (646) 452-7054
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1882559
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 12, 2024 | New notice | $173,071 | $52,324 | $120,747 | 1 | May 10, 2024 | sec.gov |
| Sep 22, 2021 | New notice | $248,540 | $248,540 | 8 | Jul 14, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Cherry | Executive Officer | |
| Craig Loverock | Director | |
| Kenneth Kovan | Executive Officer | |
| Anthony Dutton | Director | |
| James Passin | Executive Officer, Director | |
| David Berd | Executive Officer |
Every Form D from the week of Jul 8, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioVaxys Technology Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.